We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Manto Tshabalala-Msimang, the health minister, has criticised the Netcare group
for allegedly adopting bullying tactics against pharmaceutical manufacturers
under 'Innovative Medicines South Africa' (IMSA).
Shanghai Pharmaceutical Co., Ltd. will inject 166 million yuan (US$20.1 million)
in cash into the Mokom Group, a Chongqing-based private stock company, Mokom's
senior executives confirmed recently.
A major security initiative aimed at curbing the smuggling of AIDS drugs back
into Europe has been launched, with British pharmaceutical giant GlaxoSmithKline,
changing the colours, embossing and packaging of ARVs meant for the African
market.
Viropro Pharma Inc., a subsidiary of Viropro Inc.,
and ProteoCell Biotechnologies Inc. have signed a collaboration agreement to
co-commercialize specific recombinant biogeneric biotherapeutics for international
markets.
Saudi Arabia continues to modernise its pharmaceuticals sector, mainly
due to rising healthcare costs and an improved foreign direct investment regime.
The Brazilian health ministry has sent letters to three US drug firms,
Merck & Co., Abbott Laboratories and Gilead Sciences, requesting licences
to produce antiretroviral (ARV) drugs for the country's HIV/AIDS treatment programme.
Amid accelerating domestic price pressures and the lure of high margins
in Western markets, India's leading drug firms continue to seek new partnerships
to build market share on the world's largest drug markets.
A growing number of multinational drug firms are consolidating their
presence on the Indian market, amid the country's efforts to improve its patent
regime and encourage foreign participation in the local pharmaceuticals sector.
Italy's competitions regulator said Monday it opened a probe Feb.
23 to establish whether GlaxoSmithKline and Merck Co. abused their dominant
position in the pharmaceutical sector.